Guide: Beam, capitalizing on stock surge, buys gene therapy tools developer for $120M
Guide Therapeutics, the company Beam acquired, is working on ways to more efficiently deliver gene editing therapies into the body.
Read full article »
Guide Therapeutics is a Georgia-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of serious diseases.
Read more